Jersey City, New Jersey, May 03, 2021 (GLOBE NEWSWIRE) -- Verified Market Research recently published a report, “In Vivo Toxicology Market” by Testing Facility (Out-Source and In-House Testing Facility), by End User (Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Contract Research Organizations), by Toxicity End Point (Immunotoxicity, Systemic Toxicity, Genotoxicity, & Others), by Test Type (Acute, Sub-Acute, Sub-Chronic, & Chronic), by Product (Instruments and Consumables), and by Geography. According to Verified Market Research, the Global In Vivo Toxicology Market USD 4.85 Billion in 2020 and is projected to reach USD 7.34 Billion by 2028, growing at a CAGR of 5.31% from 2021 to 2028.
Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample/?rid=27349
Browse in-depth TOC on “In Vivo Toxicology Market”
202 - Pages
126 – Tables
37 – Figures
Global In Vivo Toxicology Market Overview
An important driver of growth of the Global In Vivo Toxicology market is the investment in increasing the R&D efficiency. An increasing number of pharma companies and medical device manufacturers focus on innovation and increasing their R&D efficiencies. The changing dynamics of the healthcare market in terms of its significance due to a rising number of populations needing medical attention in various countries have compelled pharmaceutical and biotechnology companies to develop drugs that are used to mitigate the combat the disease-causing pathogen without heavy side effects.
R&D activities, however, are associated with a high risk of failure. In the U.S., only 5 in 5000 drugs that are able to progress to the preclinical trial phase progress for its administration on human beings. Also, it is very important to increase the approval rate of drug in phase I, which, at present is R&D’s foremost objective. To achieve this, a large amount of R&D is conducted in the early stages of drug development. The in vivo toxicology method activities are likely to increase due to this intensive R&D in the earlier stages, which is expected to drive the market. Before the drug reaches the more expensive clinical stage. Biotechnology Industry Organization (BIO) in 2019 states that R&D investments in emerging therapeutics and novel drugs by emerging growth companies (EGCs) in the U.S. over the last decade constitute about 82.7% of the total venture capital investments.
Key Developments in In Vivo Toxicology Market
•Harbour BioMed (HBM) on March 2021 announced the dosing of the first patient in its open Phase I clinical study of HBM4003 for Chinese patients suffering from advanced melanoma and other solid tumors.
•On 31st March 2020, Danaher Corporation announced the completion of its acquisition of the Biopharma business from General Electric Company's Life Sciences division. The business was named Cytiva and will be a standalone operating company within Danaher's Life Sciences segment.
• Thermo Fisher Scientific Inc, the world leader in serving science, today announced the launch of the Thermo Scientific AerosolSense Sampler, a new surveillance solution designed to deliver fast and highly reliable insight into the presence of in-air pathogens, including SARS-CoV-2.
The major players in the market are Danaher Corporation (U.S.), Envigo (U.S.), Charles River Laboratories (U.S.), Waters Corporations (U.S.), Bruker Corporation (U.S.), Transcure BioServices SAS (France), GenOway S.A. (France), Harbour BioMed (U.S.), Merck KGaA (Germany), GVK Biosciences Pvt. Ltd. (India) among others.
Verified Market Research has segmented the Global In Vivo Toxicology Market On the basis of Testing Facility, End User, Toxicity End Point, Test Type and Product and Geography.
- In Vivo Toxicology Market by Testing Facility
- Out-Sourced Testing Facility
- In-House Testing Facility
- In Vivo Toxicology Market by End User
- Academic and Research Institutes
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations
- Other End Users
- In Vivo Toxicology Market by Toxicity End Point
- Immunotoxicity
- Systemic toxicity
- Carcinogenicity
- Genotoxicity
- Developmental & reproductive toxicity (DART)
- Other toxicity endpoints
- In Vivo Toxicology Market by Test Type
- Acute
- Sub-acute
- Sub-chronic
- Chronic
- In Vivo Toxicology Market by Product
- Instruments
- Consumable
- In Vivo Toxicology Market by Geography
- North America
- U.S
- Canada
- Mexico
- Europe
- Germany
- France
- U.K
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Rest of Asia Pacific
- ROW
- Middle East & Africa
- Latin America
- North America
Browse Related Reports:
In Vitro Diagnostics Market by Product & Services (Reagents and Kits, Instruments, Data Management Software, and Services), by Technology (Immunochemistry or Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation and Hemostasis, Urinalysis, and Others), by End User (Laboratories, Hospitals, Academics, Point -of -Care Testing, Patient Self Testing, and Others), by Application (Diabetes, Infectious Diseases, Oncology or Cancer, Cardiology, Nephrology, Autoimmune Diseases, Drug Testing, or Pharmacogenomics, HIV or AIDS and Others), by Geography, Forecast, 2020-2027
Laboratory Proficiency Testing Market by Industry Type (Clinical Diagnostics, Microbiology, Pharmaceuticals, Biologics, and Others), by Technology (Polymerase Chain Reaction, Immunoassays, Chromatography, Spectrometry, and Other Technologies), by Geography, Forecast, 2020-2027
In Vitro Toxicology Testing Market by Toxicity End Point And Test Results (ADME, Skin Irritation, Corrosion, & Sensitization, Genotoxicity Testing, Cytotoxicity Testing, Ocular Toxicity, Organ Toxicity, Phototoxicity Testing, Dermal Toxicity, Other Toxicity Endpoints & Tests), by Products And Services (Consumables, Assays, Equipment, Services, and Software), by Technology (Cell Culture Technologies, High-throughput Technologies, Toxicogenomics), by Geography, Forecast, 2020-2027
Autoimmune Disease Diagnostics Market by Product (Drugs, Therapeutic & Monitoring Equipment, and Diagnostic Equipment), by Type (Localized Autoimmune Disease Diagnostic and Systemic Autoimmune Disease Diagnostic), by Technology (Bridge Therapy, Disease-modifying Antirheumatic Drugs (DMARD), Topical Therapy, Phototherapy, Helminthic Therapy, and Recombinant Technology), by Geography, Forecast, 2020-2027
Top 10 next-generation sequencing companies changing lives with genome research
Visualize In Vivo Toxicology Market using Verified Market Intelligence:-:
Verified Market Intelligence is our BI Enabled Platform for narrative storytelling of this market. VMI offers in-depth forecasted trends and accurate Insights on over 20,000+ emerging & niche markets, helping you make critical revenue-impacting decisions for a brilliant future.
VMI provides a holistic overview and global competitive landscape with respect to Region, Country, and Segment, and Key players of your market. Present your Market Report & findings with an inbuilt presentation feature saving over 70% of your time and resources for Investor, Sales & Marketing, R&D, and Product Development pitches. VMI enables data delivery In Excel and Interactive PDF formats with over 15+ Key Market Indicators for your market.
About Us
Verified Market Research is a leading Global Research and Consulting firm servicing over 5000+ customers. Verified Market Research provides advanced analytical research solutions while offering information-enriched research studies. We offer insight into strategic and growth analyses, Data necessary to achieve corporate goals, and critical revenue decisions.
Our 250 Analysts and SME’s offer a high level of expertise in data collection and governance use industrial techniques to collect and analyze data on more than 15,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
We study 14+ categories from Semiconductor & Electronics, Chemicals, Advanced Materials, Aerospace & Defense, Energy & Power, Healthcare, Pharmaceuticals, Automotive & Transportation, Information & Communication Technology, Software & Services, Information Security, Mining, Minerals & Metals, Building & Construction, Agriculture industry and Medical Devices from over 100 countries.